Trials / Completed
CompletedNCT03117491
Effect of Inferior Alveolar and Gow-Gates Nerve Block Techniques for Symptomatic Mandibular Molars
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Isfahan University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Introduction: to evaluate the efficacy of inferior alveolar nerve block (IANB), Gow-Gates nerve block (GGNB), and their combination in patients with irreversible pulpitis. Methods: One hundred fifty subjects with irreversible pulpitis of a mandibular molar were selected. subjects randomly received two IANB injections or two GGNB injections or their combination of 1.8 mL 2% lidocaine with 1:100,000 epinephrine. Success was specified as no or mild pain on the basis of Heft-Parker visual analogue scale recordings up on the access cavity preparation or initial instrumentation. Data were analyzed by Kruskal-Wallis, and ANOVA tests.
Detailed description
Introduction: to evaluate the efficacy of inferior alveolar nerve block (IANB), Gow-Gates nerve block (GGNB), and their combination in patients with irreversible pulpitis. Methods: One hundred fifty subjects with irreversible pulpitis of a mandibular molar were selected. subjects randomly received two IANB injections or two GGNB injections or their combination of 1.8 mL 2% lidocaine with 1:100,000 epinephrine. Success was specified as no or mild pain on the basis of Heft-Parker visual analogue scale recordings up on the access cavity preparation or initial instrumentation. Data were analyzed by Kruskal-Wallis, and ANOVA tests.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | GGNB injections | The patients received two GGNB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine |
| PROCEDURE | IANB injections | The patients received two IANB injections of 1.8 mL 2% lidocaine with 1:100,000 epinephrine |
| PROCEDURE | GGNB + IANB injections | The patients received one GGNB injection plus one IANB injection of 1.8 mL 2% lidocaine with 1:100,000 epinephrine |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-11-01
- Completion
- 2016-12-01
- First posted
- 2017-04-18
- Last updated
- 2017-05-09
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03117491. Inclusion in this directory is not an endorsement.